StephenJacobWeedonMDFAAFP

Clinical Instructor, Family Medicine, Tufts Medical Center

Dr. Weedon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
116 Main St
Westminster Family Practice
Westminster, MA 01473
Phone+1 978-874-0535
Is this information wrong?

PubMed

Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.
Weedon, S. J., Green, N. K., McNeish, I. A., Gilligan, M. G., Mautner, V., Wrighton, C. J., Mountain, A., Young, L. S., Kerr, D. J., Searle, P. F.> ;Int J Cancer. 2000 Jun 15
Virus-directed enzyme prodrug therapy using CB1954.
Grove, J. I., Searle, P. F., Weedon, S. J., Green, N. K., McNeish, I. A., Kerr, D. J.> ;Anticancer Drug Des. 1999 Dec
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene.
Searle, P. F., Weedon, S. J., McNeish, I. A., Gilligan, M. G., Ford, M. J., Friedlos, F., Springer, C. J., Young, L. S., Kerr, D. J.> ;Adv Exp Med Biol. 1998
Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells.
Gilligan, M. G., Knox, P., Weedon, S., Barton, R., Kerr, D. J., Searle, P., Young, L. S.> ;Gene Ther. 1998 Jul
Join now to see all